Should all young cancer patients get genetic testing? study investigates
NCT ID NCT04533555
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether offering genetic testing to all young adults with cancer (ages 18-39) is better than only testing those who meet certain guidelines. About 749 participants were randomly assigned to either universal testing with a broad gene panel or standard testing based on doctor's judgment. The goal was to see which approach finds more inherited genetic risks that could affect patients and their families.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
broad gene panel for young adult cancers
What this could lead to
If successful, this could lead to a simpler, more effective way to identify genetic risks in young cancer patients and their families.
What could go wrong
This is a completed study comparing testing strategies, not a treatment trial. Results may not change current practice if universal testing proves too costly or impractical.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States